Hypertension Weight loss can lead to lower blood pressure, reducing the risk of heart disease and stroke
High Blood Pressure: Weight Loss Drugs Can Reduce Threat Overweight and obese patients taking tirzepatide saw significant decreases in their blood pressureespecially those taking the highest dose of the medicationa February study found
With regulatory approval from CDSCO, the company is introducing this GLP-1 therapy at a much lower cost (~1,290/month) compared to existing options, potentially transforming diabetes management for millions
The FDA has approved specific formulations for different indications: semaglutide 2.4 mg (Wegovy), liraglutide 3 mg (Saxenda), and tirzepatide (Zepbound) are approved for chronic weight management, while all are approved for diabetes at different doses
For women with PCOS who have struggled with traditional weight loss methods, this can make a significant difference
Scott leads a team committed to safe, personalized, and compassionate care